Alkahest
Phase 3Therapies Born from the Science of Plasma®Alkahest, a Grifols subsidiary, is a research and drug discovery company mining the deepest layers of plasma knowledge to inform the development of potential transformative therapies and solutions for patients. Integrating Advanced Technology and Plasma Expertise We leverage our experience in artificial intelligence and integrative analysis of multiomics and […]
About
Therapies Born from the Science of Plasma®Alkahest, a Grifols subsidiary, is a research and drug discovery company mining the deepest layers of plasma knowledge to inform the development of potential transformative therapies and solutions for patients. Integrating Advanced Technology and Plasma Expertise We leverage our experience in artificial intelligence and integrative analysis of multiomics and […]
Funding History
4Total raised: $177.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile